Nicotine induced behavioral locomotor sensitization

被引:62
|
作者
Domino, EF [1 ]
机构
[1] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA
关键词
dexamethasone; motor activity; nicotine; stimulation;
D O I
10.1016/S0278-5846(00)00148-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
1. Nicotine behavioral sensitization of locomotor activity was investigated in adult female Sprague Dawley rats. Five different experiments were performed with nicotine in various doses of 0.1, 0.32, or 1.0 mg/kg i.p. These included: 1) effects of daily nicotine for 6 days, 2) effects of once per week nicotine for 3 weeks, 3) effects of MK-801 on nicotine-induced locomotor activity, 4) effects of dexamethasone on nicotine-induced locomotor activity, 5) induction of tolerance to nicotine-induced locomotor sensitization and lack of cross tolerance to caffeine. 2. Locomotor activity was measured with a photoelectric computerized system. The first dose of nicotine (0.32 mg/kg) induced marked locomotor depression. Once daily injection of 0.32 mg/kg of nicotine for 6 days produced tolerance to its depressant effects and sensitized the rats to its stimulant effects. Three once weekly doses of 0.32 mg/kg of nicotine also produced tolerance to its depressant effects and some locomotor stimulation. 3. Daily pretreatment for 5 days with a dose of 0.18 mg/kg of MK-801 i.p. partially antagonized the locomotor depressant and stimulant actions of nicotine. 4. Dexamethasone (1 mg/kg i.p.) daily pretreatment barely reduced nicotine locomotor depression and only very slightly enhanced locomotor stimulation. 5. Accumulating doses of 0.32 and 1.0 mg/kg b.i.d. of nicotine produced tolerance to its locomotor stimulant effects in rats previously sensitized to 0.32 mg/kg. There was no cross-tolerance to 32 mg/kg of caffeine citrate in previously sensitized animals tolerant to the stimulant effects of nicotine.
引用
收藏
页码:59 / 71
页数:13
相关论文
共 50 条
  • [31] Behavioral sensitization to nicotine is associated with behavioral disinhibition; counteraction by citalopram
    P. Olausson
    Jörgen A. Engel
    B. Söderpalm
    Psychopharmacology, 1999, 142 : 111 - 119
  • [32] Behavioral sensitization to nicotine is associated with behavioral disinhibition: Counteraction by citalopram
    Olausson, P
    Engel, JA
    Soderpalm, B
    NORDIC JOURNAL OF PSYCHIATRY, 1998, 52 (02) : 129 - 130
  • [33] Behavioral sensitization to nicotine in female and male rats
    Ericson, Mia
    Norrsjo, Gunilla
    Svensson, Anders I.
    JOURNAL OF NEURAL TRANSMISSION, 2010, 117 (09) : 1033 - 1039
  • [34] Behavioral sensitization to nicotine is associated with behavioral disinhibition;: counteraction by citalopram
    Olausson, P
    Engel, JA
    Söderpalm, B
    PSYCHOPHARMACOLOGY, 1999, 142 (02) : 111 - 119
  • [35] Rimonabant blocks the expression but not the development of locomotor sensitization to nicotine in rats
    John E. Kelsey
    Siena Calabro
    Psychopharmacology, 2008, 198 : 461 - 466
  • [36] Rimonabant blocks the expression but not the development of locomotor sensitization to nicotine in rats
    Kelsey, John E.
    Calabro, Siena
    PSYCHOPHARMACOLOGY, 2008, 198 (04) : 461 - 466
  • [37] Behavioral sensitization to nicotine in female and male rats
    Mia Ericson
    Gunilla Norrsjö
    Anders I. Svensson
    Journal of Neural Transmission, 2010, 117 : 1033 - 1039
  • [38] Calcium channel antagonists suppress nicotine-induced place preference and locomotor sensitization in rodents.
    Biala, G
    POLISH JOURNAL OF PHARMACOLOGY, 2003, 55 (03): : 327 - 335
  • [39] Ascorbic acid antagonizes nicotine-induced place preference and behavioral sensitization in mice
    Sahraei, Hedayat
    Aliabadi, Ali Akbar
    Zarrindast, Mohammad-Reza
    Ghoshooni, Hassan
    Nasiri, Ali
    Barzegari-Sorkheh, Amir Abbas
    Yari, Maryam
    Zardooz, Homeira
    Hossein-Mardi, Leila
    Faraji, Nasrin
    Shams, Jamal
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 560 (01) : 42 - 48
  • [40] Exposure to nicotine and sensitization of nicotine-induced behaviors
    Vezina, P.
    McGehee, D. S.
    Green, W. N.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2007, 31 (08): : 1625 - 1638